NEW YORK, USA - The Michael J. Fox Foundation awarded a total of about $2.7 million to four industry research teams for pre-clinical research on potential new treatments for Parkinson's disease.

NEW YORK, USA - The Michael J. Fox Foundation awarded a total of about $2.7 million to four industry research teams for pre-clinical research on potential new treatments for Parkinson's disease.

CHICAGO — Patients with advanced Parkinson disease (PD) who received deep brain stimulation treatment had more improvement in movement skills and quality of life after six months than patients who received other medical therapy, but also had a higher risk of a serious adverse events, according to a study in the January 7 issue of JAMA.

SEATTLE - Omeros Corporation today announced that The Michael J. Fox Foundation has awarded it a $465,000 grant against milestones to support the Company's collaboration with The Parkinson's Institute to evaluate Omeros' recent discovery of a new target for the treatment of Parkinson's disease. Located in regions of the brain responsible for Parkinson's disease, Omeros is th...  More >>

University of Utah researchers dusted wild deer mice with fluorescent pink, blue, green, yellow and orange talcum powders to show which rodents most often fought or mated with others and thus were most likely to spread deadly hantavirus. The study identified bigger, older mice as the culprits.

Research on the mechanisms involved in neurodegenerative diseases such as Alzheimer's, stroke, dementia, Parkinson's and multiple sclerosis, to name a few, has taken a step forward thanks to the work of biological sciences Ph.D. student Sonia Do Carmo, supervised by Professor Éric Rassart of the Université du Québec à Montreal (UQAM) Biological Sc...  More >>

A team of scientists has discovered a new syndrome associated with severe congenital neutropenia (SCN), a rare disorder in which children lack sufficient infection-fighting white cells, and identified the genetic cause of the syndrome: mutations in the gene Glucose-6-phosphatase, catalytic subunit 3 (G6PC3).

Researchers have uncovered genetic secrets of the tuberculosis (TB) bacterium that may be contributing to the surge in multidrug resistance to the disease.

WASHINGTON — Medicines for rare disorders and diagnosing diseases contributed to a jump in U.S. drug approvals last year from a quarter-century low in 2007.

I recently watched a segment on The Discovery Channel that chronicled the daily life of Shiloh Pepin and her Maine-based family.

I recently watched a segment on The Discovery Channel that chronicled the daily life of Shiloh Pepin and her Maine-based family.

MONTREAL – When a Montreal mother and son went to the Royal Victoria Hospital for a live kidney transplant last month, they made a bet about who would be able to walk first.

NEW YORK, USA - Two doctors will take to the road on Jan. 24, at the Daytona International Speedway to raise funds and awareness for their patients, children with a rare genetic disorder. Ron Yarab, Jr. M.D., of Poland, Ohio, a physical medicine and rehab physician and Michael Gomez, M.D., of Madison, Alabama, a child psychiatrist, have both worked with children affected by ...  More >>

HALIFAX — Children at the IWK Health Centre in Halifax no longer have to miss classes — technology has brought their school work to their hospital beds.

Natalie Gatzke bounds into the room as joyful as ever, her smile big and her dark eyes shining.

JAIPUR, India - Lokesh Punia, a fifteen-year-old teenager of Jaipur, suffering from a severe skin disease, takes to making beautiful sculptures.

It was their second baby, second son, so Rachel Powderly thought nothing of it when nurses pricked the newborn’s heel shortly after birth last January to take blood.

In May, Rhett Lamb, a 3-year-old boy from St. Petersburg, Fla., did something nobody thought he could: sleep.